Reshma Kewalramani - Feb 10, 2022 Form 4 Insider Report for VERTEX PHARMACEUTICALS INC / MA (VRTX)

Role
CEO & President, Director
Signature
/s/ Sabrina Yohai, Attorney-in-Fact
Stock symbol
VRTX
Transactions as of
Feb 10, 2022
Transactions value $
-$720,590
Form type
4
Date filed
2/14/2022, 03:16 PM
Previous filing
Feb 3, 2022
Next filing
Feb 22, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Ownership Footnotes
transaction VRTX Common Stock Tax liability -$721 K -3.03 K -2.14% $237.74 139 K Feb 10, 2022 Direct